Owing to the overwhelming success of the initial announcement, PathXL plan to unveil powerful TissueMark add-on for cell counting in the US.
Online PR News – 19-March-2015 – Bel Air, MD – In December 2014 PathXL announced a significant upgrade to its award-winning automated tumor annotation and analysis software, TissueMark®. Owing to the overwhelming success of the initial announcement, PathXL plan to unveil and demonstrate this powerful TissueMark add-on for cell counting in the US for the first time, during the 104th United States & Canadian Academy of Pathology meeting.
The tumor cell counting capability is an extension to PathXL’s current TissueMark range. TissueMark is designed for the rapid and automated detection and analysis of tumor tissue on digitized H&E stained tissue samples for molecular profiling of solid tumors including next generation sequencing. TissueMark also has a strong capability in terms of efficiency, accuracy and acceleration of clinical trials that require molecular analysis. As with all of PathXL’s products, the new TissueMark application has been carefully validated against known standards and results show strong concordance with time-consuming manual counts of tumor nuclei across lung, colorectal and breast whole tissue sections.
Validation results were first unveiled by PathXL’s founder and VP for R&D, Professor Peter Hamilton at the Digital Pathology Congress in December. Following this meeting, PathXL has experienced a significant volume of enquiries and interest in this software which now provides the pathologist with three separate automated methods to count % tumor nuclei on digital slides. "One of the most sought after applications in the field of digital imaging," said Des Speed, CEO of PathXL.
The USCAP meeting will take place at the Hynes Convention Center in Boston (21st - 27th March) and attendees will have access to the exhibit hall from 21st - 25th March. You can find PathXL at booth 99 where you will also have the opportunity to meet our team of specialists offering live demonstrations of the TissueMark software.
Attending from PathXL are: John Durborow, Sales and Business Development Director for North America; Jonathon Tunstall, Director of Product Strategy and Don Ariyakumar, M.S, Technical Sales Specialist.
For more information on TissueMark visit its dedicated page or find us at USCAP exhibit hall – Booth 99.
We will be posting live updates during the conference via our Twitter account, @PathXL, using #USCAP2015. We encourage you to let us know what you think of our award-winning product using #TissueMark.
*Please note: TissueMark® is for research use only. Not for use in diagnostic procedures.